Dandelion Health, a New York-based company providing an intelligence platform for life sciences organizations, has raised $14 million in a Series A financing round led by Healthier Capital. Additional participation came from Colle Capital, alongside existing investors Moxxie Ventures, Convergent Ventures, and Primary Venture Partners.
The company’s platform integrates multiple forms of healthcare data to support research and development. It combines structured datasets, including electronic medical records and claims data, with unstructured clinical inputs and raw biological signals. These include ECG waveforms, echocardiogram videos, radiology imaging, pulmonary function tests, and ultrasound data, offering a more comprehensive view of patient health trajectories.
Dandelion Health focuses on enabling life sciences companies to better utilize clinical data to accelerate drug development and research outcomes. The newly raised capital will be directed toward scaling operations, strengthening partnerships, and enhancing its underlying data infrastructure.
Elliott Green, CEO and cofounder of Dandelion Health, emphasized the untapped potential of clinical data, stating, "Most clinical data is never seen, let alone used. ECGs, echocardiograms, radiology scans — these are generated millions of times a day, and they carry signals that no one is systematically capturing at scale. We built Dandelion to change that."
He added, "This round lets us go deeper with our pharma partners and demonstrate what's possible when the full richness of a patient's clinical record is actually brought to bear on drug development."
Recent developments highlight the company’s efforts to expand its capabilities and ecosystem. In April, Dandelion Health announced a partnership with InVision Medical Technology to incorporate echocardiography AI into its clinical AI marketplace. The integration enables analysis of cardiac ultrasound imaging, generating interpretations, disease risk assessments, and measurements not typically captured during routine clinical care.
Earlier, in 2024, the company entered a public-private partnership with the SCAN Foundation. This collaboration aims to expand Dandelion’s algorithms to incorporate social determinants of health data, with a particular focus on aging populations and historically marginalized communities.
Click here for the original news story.
